Individualizing COPD Treatment Using the GOLD Guidelines

Pri-Med Podcasts

Pri-Med에서 제공하는 콘텐츠입니다. 에피소드, 그래픽, 팟캐스트 설명을 포함한 모든 팟캐스트 콘텐츠는 Pri-Med 또는 해당 팟캐스트 플랫폼 파트너가 직접 업로드하고 제공합니다. 누군가가 귀하의 허락 없이 귀하의 저작물을 사용하고 있다고 생각되는 경우 여기에 설명된 절차를 따르실 수 있습니다 https://ko.player.fm/legal.

5y ago 21:53

MP3•에피소드 홈

Credits: 0.25 AMA PRA Category 1 Credit™

CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/gsk-cme-copd-2

Overview: Join pulmonologist Dr. Matthew Drake as he discusses the current 2020 GOLD guidelines for treatment of COPD. Using patient case examples, he will outline how to assess patients with COPD to determine the most appropriate evidence-based treatment. Discussion will include which patients will benefit most from inhaled corticosteroids and when to consider triple inhaled therapy with combination of long-acting beta-2-agonist, long acting muscarinic antagonist and inhaled corticosteroids.

Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 10/9/2020 and they are subject to change as new information is published.

Guest: Matthew G. Drake, MD

569 에피소드

#Science #Medical #PriMed Podcasts #Podcasting Education #FAQ #Prime